INIS RADNOSTIX INC
Industrial Instruments For Measurement, Display, and Control · OTC · SEC CIK 1038277 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-25.3%
TTM net income YoY-1,414.8%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin53.4%
Operating margin-33.3%
Net margin-33.3%
FCF margin-11.5%
EBITDA margin-29.3%
Returns
ROE-116.3%
ROA-20.2%
ROIC (approx.)-151.2%
Asset turnover0.61x
Leverage & solvency
Liabilities / assets88.6%
Debt / equity0.00x
Current ratio0.68x
Interest coverage-10.15x
Cash quality & payout
Operating cash flow / net income0.21x
Accruals ratio-16.0%
Payout ratio—
Capex / revenue4.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $13.07M | $13.90M |
| Cost of revenue | $5.37M | $5.25M |
| Gross profit | $7.70M | $8.65M |
| R&D expense | $435,840 | $610,737 |
| SG&A expense | $3.73M | $4.01M |
| Operating income | -$956,187 | $6,901 |
| Interest expense | $339,281 | $328,678 |
| Income tax | $0 | $0 |
| Net income | -$908,002 | $8,574 |
| EBITDA | -$553,747 | $407,968 |
| EPS (basic) | 0.00 | 0.00 |
| EPS (diluted) | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 526.80M | 522.29M |
| Balance sheet | ||
| Cash & equivalents | $1.70M | $1.95M |
| Receivables | $1.42M | $1.52M |
| Inventory | $875,449 | $820,893 |
| Current assets | $4.63M | $4.99M |
| PP&E, net | $3.69M | $3.30M |
| Goodwill | $1.38M | $1.38M |
| Intangibles | $3.21M | $3.37M |
| Total assets | $17.84M | $17.16M |
| Current liabilities | $3.97M | $3.33M |
| Short-term debt | $162,715 | $308,399 |
| Long-term debt | $1.93M | $2.21M |
| Total debt | $2.09M | $2.52M |
| Total liabilities | $14.14M | $12.81M |
| Shareholders' equity | $3.69M | $4.35M |
| Net debt | $399,253 | $570,172 |
| Shares outstanding | 528.21M | 523.55M |
| Cash flow statement | ||
| Operating cash flow | $620,163 | $638,783 |
| Capital expenditure | $534,155 | $721,215 |
| Free cash flow | $86,008 | -$82,432 |
| Investing cash flow | -$534,155 | -$685,215 |
| Financing cash flow | -$275,856 | -$145,228 |
| Depreciation & amortization | $402,440 | $401,067 |
| Stock-based compensation | $117,822 | $199,420 |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.